MTP

Midatech Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.300
+0.030
+2.36%
Opening 11:01 04/06 EDT
OPEN
1.270
PREV CLOSE
1.270
HIGH
1.377
LOW
1.270
VOLUME
8.23K
TURNOVER
--
52 WEEK HIGH
19.30
52 WEEK LOW
0.8620
MARKET CAP
--
P/E (TTM)
-0.1129
1D
5D
1M
3M
1Y
5Y

MTP News

More
  • Midatech Pharma Says Decided to Terminate Further Inhouse Development of MTD201 Program With Immediate Effect; CEO Steps Down; Board Conducting Strategic Review
  • Benzinga · 6d ago
  • Midatech Pharma PLC Announces Strategic Review, Update and Directorate Changes
  • ACCESSWIRE · 6d ago
  • The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment
  • Benzinga · 03/17 15:38
  • 90 Biggest Movers From Yesterday
  • Benzinga · 03/12 10:10

Industry

Biotechnology & Medical Research
+3.95%
Pharmaceuticals & Medical Research
+3.15%

Hot Stocks

Symbol
Price
%Change

About MTP

Midatech Pharma PLC is an early-stage biopharmaceutical company that focuses on commercializing and developing products in oncology and other therapeutic areas. The Company's segments include Pipeline Research and Development, and Commercial. The Pipeline Research and Development segment seeks to develop products using the nanomedicine and sustained release technology platforms. The Commercial segment distributes and sells the commercial products. Its products include Zuplenz, Gelclair, Oravig and Soltamox. Zuplenz is an oral soluble film indicated for moderately emetogenic chemotherapy-induced nausea and vomiting (CINV), radiotherapy-induced nausea and vomiting (RINV), and post-operative nausea and vomiting (PONV). Gelclair is a product indicated for the management and relief of pain due to oral mucositis. Oravig is an orally dissolving buccal tablet approved for oral thrush. Soltamox is an oral liquid solution of tamoxifen citrate for the prevention of breast cancer.
More

Webull offers kinds of Midatech Pharma PLC-ADR stock information, including NASDAQ:MTP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MTP stock news, and many more online research tools to help you make informed decisions.